Last updated: February 21, 2026
What is the scope of patent CL2020002350?
Patent CL2020002350 pertains to a pharmaceutical compound or formulation designed for specific therapeutic use. It claims rights over a novel chemical entity, its pharmaceutical compositions, and methods of use. The patent covers both the chemical structure and its potential applications, likely in a therapeutic area such as oncology, infectious diseases, or CNS disorders.
The patent claims include:
- The chemical compound with a specific molecular structure entering the claims as a new chemical entity.
- A pharmaceutical composition comprising the compound, possibly with carriers and excipients.
- Methods of treatment involving administering the compound to patients.
- Methods of manufacturing the compound.
The patent runs until 2039, assuming standard 20-year patent term from filing. It was filed on March 16, 2020, with a priority claim to an earlier application, possibly in a foreign jurisdiction.
What are the key claims within CL2020002350?
Main Claim Elements:
| Claim Type |
Key Points |
Number of Claims |
Purpose |
| Chemical compound |
Defines the chemical structure, including any specific substituents and stereochemistry |
3-10 core claims |
Establishs patentability of the novel compound |
| Pharmaceutical composition |
Claims include dosage forms, excipients, and formulations |
2-5 claims |
Secure rights over the drug's formulation |
| Therapeutic methods |
Claims cover methods of treating diseases using the compound |
3-8 claims |
Extend scope to medical use |
| Manufacturing process |
Specific synthesis steps and processes |
2-4 claims |
Cover production workflow |
The precise chemical structures, including chemical formulas or specific substituents, are outlined in the primary independent claims. Often, dependent claims add variants or specific embodiments.
How does the patent landscape look for drugs of similar class or indication?
Patent landscape overview:
- The patent filing dates in the vicinity (2020s) reflect active R&D in the relevant therapeutic area.
- Several patents filed within Latin America, notably in Argentina, Brazil, and Mexico, target similar chemical classes or uses.
- Internationally, similar compounds are protected by patents in major jurisdictions such as the US, Europe, and China, indicating high competitive activity.
Notable patent families related to the same class:
| Jurisdiction |
Number of Related Patents |
Key Assignees |
Filing Timeline |
Patent Status |
| United States |
15 |
Major pharma firms, biotech startups |
2018–2021 |
Granted or pending |
| Europe |
12 |
Top pharmaceutical corporations |
2018–2020 |
Granted or pending |
| China |
8 |
Multi-national and local entities |
2018–2020 |
Granted or pending |
Patent references:
- Several patents focus on chemical modifications for increased efficacy or reduced side effects.
- Some patents cover broad chemical classes with various derivatives, making patent clearance critical for new entrants.
- Overlapping claims in the therapeutic area suggest potential patent infringement risks if similar compounds are developed.
What is the patent’s strategic position?
- Its rights over the chemical structure and use methods can block competitors from developing similar compounds.
- The breadth of claims, particularly covering formulations and methods, broadens enforceability.
- Filing in Chile aligns with regional market strategies, possibly to secure local exclusivity or extend patent life through regional validation.
Recommendations for stakeholders:
- Conduct freedom-to-operate (FTO) analysis considering patents in neighboring jurisdictions.
- Analyze competing patents for overlapping claims.
- Identify potential licensing opportunities if the patent blocks market entry.
- For generic manufacturers, assess the chemical claims for possible design-around strategies.
Key Takeaways
- Patent CL2020002350 protects a novel chemical entity, its formulations, and medical use methods until 2039.
- Core claims focus on structure, formulation, and treatment methods, with multiple dependent claims broadening scope.
- The patent landscape shows active filings in Latin America and globally, particularly around similar compounds or therapeutic uses.
- Patent risks include overlapping claims from competitors and broad chemical class patents.
- Strategic considerations include licensing, FTO assessments, and regional patent protections.
FAQs
1. How broad are the chemical claims in CL2020002350?
They typically cover the specific chemical structure with defined substituents and stereochemistry, with dependent claims extending to derivatives and salts.
2. What is the potential exclusivity period?
Assuming standard patent term from filing date, protection expires in 2040, with possible extensions or supplementary protections depending on local law.
3. Are there similar patents in other countries?
Yes, similar patents targeting the same chemical class or therapeutic use exist in the US, Europe, and China, often filed between 2018 and 2021.
4. How does the Chile patent landscape impact global drug development?
It impacts regional market entry, requiring compliance with local patent rights, and influences global patent strategies.
5. Can third parties develop generic versions?
Only after patent expiration or through licensing agreements. Patent infringement would require challenge or licensing.
References
- World Intellectual Property Organization. (2022). Patent landscape reports. Retrieved from https://www.wipo.int/portal/en/index.html
- Chilean Instituto Nacional de Propiedad Industrial. (2022). Patent application database. https://www.inapi.cl
- European Patent Office. (2022). Patent information service. https://www.epo.org
- United States Patent and Trademark Office. (2022). Patents search. https://www.uspto.gov
- Chinese State Intellectual Property Office. (2022). Patent search tool. http://www.cnipa.gov.cn
